IDEAS home Printed from https://ideas.repec.org/a/bla/jomstd/v55y2018i2p232-264.html
   My bibliography  Save this article

Flow Signals: Evidence from Patent and Alliance Portfolios in the US Biopharmaceutical Industry

Author

Listed:
  • Turanay Caner
  • Olga Bruyaka
  • John E. Prescott

Abstract

Integrating signalling theory and the portfolio diversity literature, we theorize that diversity in a firm's patent and alliance portfolios sends contrasting flow signals impacting its market value in a nuanced way. Diversity in an alliance portfolio mediates the patent portfolio diversity – market value relationship by suppressing the negative effect of patent portfolio diversity creating an overall positive effect. We test our mediation model on a longitudinal set of 225 US biopharmaceutical firms that were awarded 17,078 patents and participated in 37,744 alliances between 1990 and 2006. Our theory and findings contribute three novel insights. First, we demonstrate the value of a temporal lens in explaining why diversity in a firm's patent and alliance portfolios send flow signals that establish expectations among market observers and have performance implications. Second, establishing that patent and alliance portfolio diversity are temporally sequenced provides compelling evidence for the value of studying multiple types of portfolios, their temporal relationships and effects on firm outcomes. Third, since diversity in a firm's portfolios can send contrasting flow signals conditioned on the cognitive demands and proximity involved in interpreting the signals, firms that do not maintain a ‘signalling fit’ with market observers increase the probability of unintentional negative signalling effects.

Suggested Citation

  • Turanay Caner & Olga Bruyaka & John E. Prescott, 2018. "Flow Signals: Evidence from Patent and Alliance Portfolios in the US Biopharmaceutical Industry," Journal of Management Studies, Wiley Blackwell, vol. 55(2), pages 232-264, March.
  • Handle: RePEc:bla:jomstd:v:55:y:2018:i:2:p:232-264
    DOI: 10.1111/joms.12217
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/joms.12217
    Download Restriction: no

    File URL: https://libkey.io/10.1111/joms.12217?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Cheng‐Wei Wu & Jeffrey J. Reuer, 2021. "Acquirers’ Reception of Signals in M&A Markets: Effects of Acquirer Experiences on Target Selection," Journal of Management Studies, Wiley Blackwell, vol. 58(5), pages 1237-1266, July.
    2. Gnekpe, Christian & Jimenez, Alfredo, 2023. "Smoke signal: When firms' patent strategy and local patent protection system affect equity stakes in cross-border acquisitions," Journal of International Management, Elsevier, vol. 29(6).
    3. Su, Taoyong & Yu, Yuzhu & Chen, Yongheng & Hou, Wanrong, 2023. "On or off: The triggering effect of underperformance duration on cooperative innovation," Technovation, Elsevier, vol. 126(C).
    4. Chaturvedi, Tuhin & Prescott, John E., 2020. "Dynamic Fit In An Era Of Ferment: Product Design Realignment And The Survival-Enhancing Role Of Alliances And Acquisitions," Research Policy, Elsevier, vol. 49(6).
    5. Thakur-Wernz, Pooja & Bruyaka, Olga & Contractor, Farok, 2022. "Sourcing portfolio diversity in new product development: Antecedents and performance implications," Journal of Business Research, Elsevier, vol. 150(C), pages 179-193.
    6. Ad Jong & Nicolas A. Zacharias & Edwin J. Nijssen, 2021. "How young companies can effectively manage their slack resources over time to ensure sales growth: the contingent role of value-based selling," Journal of the Academy of Marketing Science, Springer, vol. 49(2), pages 304-326, March.
    7. Ghosh, Anindya & Klueter, Thomas, 2022. "The role of frictions due to top management in alliance termination decisions: Insights from established bio-pharmaceutical firms," Other publications TiSEM 9faa19d2-d1a8-4490-befb-d, Tilburg University, School of Economics and Management.
    8. Yuanyuan Dong & Zepeng Wei & Tiansen Liu & Xinpeng Xing, 2020. "The Impact of R&D Intensity on the Innovation Performance of Artificial Intelligence Enterprises-Based on the Moderating Effect of Patent Portfolio," Sustainability, MDPI, vol. 13(1), pages 1-17, December.
    9. Ruey‐Jer “Bryan” Jean & Daekwan Kim, 2021. "Signalling Strategies of Exporters on Internet Business‐to‐Business Platforms," Journal of Management Studies, Wiley Blackwell, vol. 58(7), pages 1869-1898, November.
    10. Koval, Mariia & Iurkov, Viacheslav & Benito, Gabriel R.G., 2024. "The interplay of international alliance and subsidiary portfolios: Implications for firms’ innovation and financial performance," Journal of World Business, Elsevier, vol. 59(1).
    11. Joseph P. Broschak & Emily S. Block & Sharon Koppman & Idris Adjerid, 2020. "Will We Ever Meet Again? The Relationship between Inter‐Firm Managerial Migration and the Circulation of Client Ties," Journal of Management Studies, Wiley Blackwell, vol. 57(6), pages 1106-1142, September.
    12. Shuman Zhang & Changhong Yuan & Yuying Wang, 2019. "The Impact of Industry–University–Research Alliance Portfolio Diversity on Firm Innovation: Evidence from Chinese Manufacturing Firms," Sustainability, MDPI, vol. 11(8), pages 1-16, April.
    13. Joseph J. Cabral & Chaoqun Deng & M. V. Shyam Kumar, 2020. "Internal Resource Allocation and External Alliance Activity of Diversified Firms," Journal of Management Studies, Wiley Blackwell, vol. 57(8), pages 1690-1717, December.
    14. Shuman Zhang & Changhong Yuan & Chen Han, 2020. "Industry–university–research alliance portfolio size and firm performance: the contingent role of political connections," The Journal of Technology Transfer, Springer, vol. 45(5), pages 1505-1534, October.
    15. Anindya Ghosh & Thomas Klueter, 2022. "The Role of Frictions due to Top Management in Alliance Termination Decisions: Insights from Established Bio‐Pharmaceutical Firms," Journal of Management Studies, Wiley Blackwell, vol. 59(5), pages 1315-1353, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:jomstd:v:55:y:2018:i:2:p:232-264. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www.blackwellpublishing.com/journal.asp?ref=0022-2380 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.